All Categories

Scimitar syndrome with vein stenosis in an infant

Fany Corvol, Sébastien Hascoet, Emmanuel Le Bret, Nadia NathanSorbonne University. Université Paris-Saclay, Marie-Lannelongue Surgical Centre. Ramsay Santé, Clinique du Sport. Sorbonne University.France British Medical Journal Case ReportsBMJ Case Rep 2024; 17:DOI: 10.1136/bcr-2024-259955 AbstractScimitar syndrome is characterised by right lung hypoplasia and abnormal pulmonary venous return, known as the ‘scimitar vein’. We report the case of an infant girl […]

Scimitar syndrome with vein stenosis in an infant Read More »

Therapeutic effects of treat and repair strategy in pediatric patients with pulmonary arterial hypertension and simple congenital heart defects

Xiaofeng Wang, Shilin Wang, Zhongyuan Lu, Wenlong Wang, Xu WangFuWai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College.China Pulmonary CirculationPulm Circ 2024; 14: DOI: 10.1002/pul2.12387 AbstractSurgical indications for patients with pulmonary arterial hypertension (PAH) and congenital heart defects are controversial. The treat and repair strategy has demonstrated efficacy in adult populations, but there

Therapeutic effects of treat and repair strategy in pediatric patients with pulmonary arterial hypertension and simple congenital heart defects Read More »

Persistent Pulmonary Hypertension of the Newborn: Should Sildenafil and Inhaled Nitric Oxide at Medium Concentration Be the Standard of Treatment?

Ivan D. Florez, Luisa Parra-RodasUniversidad de Antioquia. McMaster University. Clínica Las Américas-AUNA. Universidad Pontificia Bolivariana.Columbia and Canada Critical Care MedicineCrit Care Med 2024; 52: 995-997DOI: 10.1097/CCM.0000000000006278 AbstractAbstract Not Available (Editorial) CategoryClass I. Persistent Pulmonary Hypertension of the NewbornMedical Therapy. Efficacy or Lack of Efficacy Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Filed (PHiled).

Persistent Pulmonary Hypertension of the Newborn: Should Sildenafil and Inhaled Nitric Oxide at Medium Concentration Be the Standard of Treatment? Read More »

Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis

Ruixi Zhou, Yupeng lei, long Ge, Qian Mao, liuping Yang, Xia QiuWest China Second University Hospital. Sichuan University. Lanzhou University. China Annals of MedicineAnn Med 2024; 56:DOI: 10.1080/07853890.2024.2352603 AbstractObjective: Pulmonary hypertension (PH) is a life-threatening disease, especially in paediatric population. Symptoms of paediatric PH are non-specific. Accurate detection of paediatric PH is helpful for early treatment and

Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis Read More »

Milrinone in persistent pulmonary hypertension of newborn: a scoping review

Radu Galis, Diane Mudura, Paula Trif, Shivashankar Diggikar, Arun Prasath, Maria Livia Ognean, Jan Mazela, Adrian Lacatusu, Rangasamy Ramanathan, Boris W. Kramer, Yogen SinghEmergency County Hospital Bihor. Poznan University of Medical Sciences. University of Oradea. Oyster Woman and Child Hospital. University of Texas Southwestern. Lucian Blaga University Sibiu. Clinical County Emergency Hospital Sibiu. Emergency County

Milrinone in persistent pulmonary hypertension of newborn: a scoping review Read More »

Splenectomy is significantly associated with thrombosis but not with pulmonary hypertension in patients with transfusion-dependent thalassemia: a meta-analysis of observational studies

Tsampika-Vasileia Kalamara, Konstantino Dodos, Efthymia VlachakiHippokration General Hospital and Aristotle University of Thessaloniki.Greece Frontiers in MedicineFront Med 2023; 10: DOI: 10.3389/fmed.2023.1259785 AbstractIntroduction: Thromboembolism (TE) and pulmonary hypertension (PH) constitute frequently occurring complications in patients with transfusion-dependent thalassemia and have been associated with splenectomy in different studies. Nevertheless, the size of the possible association varies greatly in literature. Herein,

Splenectomy is significantly associated with thrombosis but not with pulmonary hypertension in patients with transfusion-dependent thalassemia: a meta-analysis of observational studies Read More »

Hemodynamic management of congenital diaphragmatic hernia: the role of targeted neonatal echocardiography

Aimann Surak, Linda Mahgoub, Joseph Y. TingUniversity of Alberta.Canada World Journal of Pediatric SurgeryWorld J Pediatr Surg 2024; 7: DOI: 10.1136/wjps-2024-000790 AbstractCongenital diaphragmatic hernia (CDH) is a major congenital anomaly, resulting from the herniation of abdominal contents into the thoracic cavity, thereby impeding the proper development of the lungs and pulmonary vasculature. CDH severity correlates with

Hemodynamic management of congenital diaphragmatic hernia: the role of targeted neonatal echocardiography Read More »

Neonatal outcomes of preterm infants with pulmonary hypertension: clustering based on prenatal risk factors

Seong Phil Bae, Sung Shin Kim, Jungha Yun, Hanbyul Lee, Won-Ho Hahn, Suyeon ParkSoonchunhyang University Seoul Hospital, Bucheon Hospital, and College of Medicine. Catholic University of Korea Eunpyeong St. Mary’s Hospital. Inha University Hospital. Chung-Ang University.Republic of Korea Pediatric ResearchPediatr Res 2024; DOI: 10.1038/s41390-024-03232-1 AbstractBackground: To investigate association of prenatal risk factors and neonatal outcomes of preterm

Neonatal outcomes of preterm infants with pulmonary hypertension: clustering based on prenatal risk factors Read More »

Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension

Madeline Grossman, Stephen Walker, E. Zachary RamseyChildren’s Hospital of Philadelphia.United States Pediatric CardiologyPediatr Cardiol 2024; DOI: 10.1007/s00246-024-03513-w AbstractThis retrospective chart review of patients less than 18 years old with pulmonary arterial hypertension (PAH) receiving selexipag was conducted to describe selexipag dosing practices, impact on concomitant PAH therapies, and the safety and efficacy of selexipag. Twenty-seven patients

Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension Read More »

Fatal pulmonary arterial hypertension (PAH): A rare association of anti-MDA-5 positive juvenile dermatomyositis

R. Shreyas, Anagha Patteri, M. B. Hayagrivas, Tanya Singla, Shivaprasad Pannasamudra Mohankumar, Saurabh Kumar Gupta, Manisha Jana, Narendra Kumar Bagri, A. V. RamananAll India Institute of Medical Sciences. Bristol Royal Hospital for Children.India and United Kingdom International Journal of Rheumatic DiseasesInt J Rheum Dis 2024; 27: DOI: 10.1111/1756-185X.15180 AbstractAbstract Not Available CategoryClass I. Pulmonary Hypertension Associated

Fatal pulmonary arterial hypertension (PAH): A rare association of anti-MDA-5 positive juvenile dermatomyositis Read More »

Scroll to Top